# Henry Schein, Inc > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Henry Schein, Inc). ## Overview Henry Schein is a health care solutions company that distributes products and provides services primarily to office-based dental and medical practitioners, as well as alternate sites of care. It combines broad consumables and equipment distribution with specialty manufacturing and practice software, positioning itself as a single-source supplier for clinical and practice-management needs. ## Products & services • Dental and medical consumables, equipment, and pharmaceuticals • Home health products and direct-to-patient supplies • Dental implants, biomaterials, endodontic, orthodontic, orthopedic products • Practice management software, revenue cycle management, and patient tools • Equipment repair, installation, and technical services • Consulting, continuing education, and practice services - **Global Distribution and Value-Added Services** (72%) — Distribution of branded and corporate-brand consumables, equipment, pharmaceuticals, and related services for dental and medical practices. - **Global Specialty Products** (18%) — Manufactured and specialty dental and health care products including implants, biomaterials, endodontic, orthodontic, and orthopedic offerings. - **Global Technology** (8%) — Practice management software, cloud-based tools, revenue cycle management, and patient relationship solutions. - **Home Health and Alternate Care** (2%) — Medical supplies and devices delivered directly to patients and alternate care settings through the distribution network. - Dental and medical consumables, equipment, and pharmaceuticals - Home health products and direct-to-patient supplies - Dental implants, biomaterials, endodontic, orthodontic, orthopedic products - Practice management software, revenue cycle management, and patient tools - Equipment repair, installation, and technical services - Consulting, continuing education, and practice services ## Customers The company sells to a wide base of office-based health care providers, including dental practices, physician practices, laboratories, ambulatory surgery centers, and alternate care clinics. It also serves larger organized buyers such as DSOs, GPOs, HMOs, IDNs, government, and institutional health care customers that value scale, pricing, and practice-management support. - **Dental practices** (primary) — Buy consumables, equipment, implants, biomaterials, and software to run chairside operations and improve practice efficiency. - **Physician practices and ambulatory surgery centers** (primary) — Buy medical supplies, pharmaceuticals, equipment, and service support for office-based and outpatient care. - **DSOs, GPOs, and managed care organizations** (primary) — Buy at scale for multiple locations and value competitive pricing, centralized ordering, and management information support. - **Labs, institutional clinics, and alternate care providers** (secondary) — Buy recurring supplies and services for specialized care settings and non-hospital delivery models. - **Home health patients and providers** (secondary) — Buy direct-to-patient medical supplies and devices for chronic care and home-based treatment adherence. - Dental practices buying consumables, equipment, and specialty products - Physician practices and ambulatory surgery centers needing broad supply access - DSOs and GPOs seeking pricing, multi-site fulfillment, and management tools - Labs and alternate care providers using recurring consumables and services - Government and institutional clinics purchasing through centralized channels ## Geography Henry Schein is headquartered in Melville, New York and operates in 34 countries and territories, with a workforce split roughly 48% in the U.S. and 52% outside the U.S. Its distribution and manufacturing footprint spans 38 distribution centers and 17 manufacturing facilities, supporting local fulfillment and service delivery across North America, Europe, and other international markets. - Headquartered in Melville, New York, with global operations in 34 countries and territories - About 48% of employees are based in the United States and 52% outside the U.S. - 38 distribution centers support rapid fulfillment and local inventory availability - 17 manufacturing facilities support specialty products and corporate-brand offerings - North America and Europe are key markets for dental and medical distribution ## Strategy The company is focused on being a single-source supplier by combining broad distribution, specialty products, and software-enabled services. Its strategy emphasizes customer retention through e-commerce, field sales, practice services, and acquisitions that add customers, geographies, and new technologies. - **Broaden the integrated product-and-service platform** (medium-term) — A wider offering increases customer stickiness and supports cross-selling across dental and medical accounts. - **Grow cloud-based and recurring technology revenue** (medium-term) — Software and revenue cycle management carry higher margins and deepen workflow integration with customers. - **Use acquisitions to expand footprint and product access** (medium-term) — Acquisitions can add customers, sales teams, and new technologies faster than organic growth alone. - **Improve operating efficiency and fulfillment reliability** (short-term) — Distribution economics depend on inventory availability, logistics, and service quality. - Expand the single-source offering across products, services, and software - Use e-commerce and omnichannel sales to improve ordering convenience - Grow specialty products and cloud software to lift margins - Acquire businesses that add customers, sales teams, and geographies - Invest in customer service, technical support, and practice efficiency tools ## Risks The business depends on third-party suppliers for a large share of distributed products and raw materials, so supply disruption or supplier concentration can affect availability, rebates, and margins. It also faces intense competition from distributors, manufacturers selling direct, and online commerce, while cybersecurity and data privacy remain material operational risks after the 2023 incident. - **Third-party supplier concentration and supply disruption** [high] — The company sources a significant volume of products from external suppliers without long-term contracts. - **Manufacturers selling direct to end customers** [high] — Direct sales can reduce the role of distributors and compress margins in dental and medical categories. - **Cybersecurity and data breach exposure** [high] — The company processes sensitive health, billing, and patient data across global systems. - **Competitive pricing pressure** [medium] — Customers can source many products from multiple distributors and online channels. - **Acquisition and integration execution** [medium] — Growth strategy relies partly on acquisitions that must be integrated into sales, systems, and operations. - Supplier dependence can disrupt product availability and pricing - Direct sales by manufacturers can bypass distribution margins - Cybersecurity incidents can interrupt operations and create remediation costs - Private-label and low-cost competitors can pressure pricing and share - Working capital swings and seasonality can strain liquidity - Acquisitions and integration can fail to deliver expected synergies ## Accounting Working capital and seasonality are important because sales tend to be stronger in the second half of the year and inventory buy-ins can lift quarter-to-quarter volatility. Investors should also watch goodwill and intangible asset impairment, redeemable noncontrolling interests, and restructuring charges, since acquisitions and portfolio changes can materially affect reported earnings and balance-sheet values. - **Seasonality and working capital** — Quarterly cash flow and balance-sheet comparability - **Goodwill and intangible asset impairment** — Potential non-cash charges to earnings - **Redeemable noncontrolling interests** — Can change equity and reported obligations - **Restructuring and exit costs** — Affects operating expense trends and comparability - Seasonal inventory build and buy-ins affect quarterly cash flow and working capital - Goodwill and intangible asset impairment can create non-cash charges - Redeemable noncontrolling interests are measured at fair value and can move - Restructuring and exit costs can distort operating trends - Cyber remediation and acquisition accounting can affect comparability --- *Last updated: 2026-08-11T04:03:56.228997+00:00*